Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663155 · ClinicalTrials.gov registry record
Chest Imaging, Breath, and Biomarkers in a Screening Trial
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 1,424
- Enrollment target
NCT01663155 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,424 participants.
The verdict
NCT01663155 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 1,424 participants
- Enrollment target
Study Summary
The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.
Interventions
- DEVICE chest x-ray with or without CAD, lose dose CT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,424 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01663155
The ClinicalTrials.gov registry entry for NCT01663155 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,424 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which chest x-ray with or without CAD, lose dose CT scan is the first listed.
NCT01663155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01663155 about?
NCT01663155 is a clinical study titled "Chest Imaging, Breath, and Biomarkers in a Screening Trial". The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence o...
What is the current status of trial NCT01663155?
This trial is currently completed. The enrollment target is 1,424 participants. The study started on 2008-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01663155?
The interventions under investigation include: chest x-ray with or without CAD, lose dose CT scan (DEVICE).
Who is sponsoring clinical trial NCT01663155?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.